Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Frontiers in Molecular Biosciences|January 23, 2024
One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexesAlice Castaldo, Monica Gelzo, Paola Iacotucci, et al.
Clinical Chemistry and Laboratory Medicine|August 26, 2011
Sterol profiles in plasma and erythrocyte membranes in patients with Smith-Lemli-Opitz syndrome: a six-year experienceGaetano Corso, Monica Gelzo, Rosalba Barone, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 22, 2025
The treatment with Elexacaftor/Tezacaftor/Ivacaftor significantly increases serum bilirubin and decreases blood platelets in children and adolescents with cystic fibrosis homozygous or double heterozygous for the F508del CFTR variantAlice Castaldo, Chiara Cimbalo, Cristina Fevola, et al.
Journal of Clinical Medicine|July 29, 2025
Hemoglobin Levels in Children Treated for Cystic Fibrosis with CFTR Modulators: A Single Center Retrospective StudyAntonella Tosco, Raffaele Cerchione, Monica Gelzo, et al.
Research in Veterinary Science|December 14, 2024
Effect of the sarcoptic mange upon metabolome profiling in wild boarsNadia Piscopo, Michele Costanzo, Monica Gelzo, et al.
Cytokine|November 2, 2024
Serum endocan (ESM-1) as diagnostic and prognostic biomarker in Multisystem inflammatory syndrome in children (MIS-C)Alessandro Cannavo, Monica Gelzo, Caterina Vinciguerra, et al.
Diagnostics (Basel, Switzerland)|February 11, 2021
NGS Gene Panel Analysis Revealed Novel Mutations in Patients with Rare Congenital Diarrheal DisordersMaria Valeria Esposito, Marika Comegna, Gustavo Cernera, et al.
Scientific Reports|January 12, 2023
Lipidomic alterations in human saliva from cystic fibrosis patientsMarianna Caterino, Roberta Fedele, Vincenzo Carnovale, et al.
Diagnostics (Basel, Switzerland)|November 11, 2020
Impaired Ratio of Unsaturated to Saturated Non-Esterified Fatty Acids in Saliva from Patients with Cystic FibrosisMonica Gelzo, Paola Iacotucci, Vincenzo Carnovale, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 27, 2020
Lumacaftor/ivacaftor improves liver cholesterol metabolism but does not influence hypocholesterolemia in patients with cystic fibrosisMonica Gelzo, Paola Iacotucci, Mafalda Caputo, et al.
Pageof 9